Analysis of the patent applications for insulin in Brazil

Authors

  • Carlos Eduardo Collazo Pontes Fundação Oswaldo Cruz, Instituto de Tecnologia em Fármacos, Núcleo de Inovação Tecnológica. Rio de Janeiro, RJ
  • Wanise Borges Gouvea Barroso Fundação Oswaldo Cruz, Instituto de Tecnologia em Fármacos, Núcleo de Inovação Tecnológica. Rio de Janeiro, RJ

DOI:

https://doi.org/10.29397/reciis.v12i4.1328

Keywords:

Drug, Biotechnology, Insulin, Patent, Mapping.

Abstract

Among the biotechnological drugs, insulin plays an extremely significant role because it occupies the world rank of most commercialized drugs and, in Brazil, it is the pharmaceutical input that generates more expenses with importation. Insulin is one of the main medicines used for diabetes, the disease that affects 415 million people and consumes 12% of the world’s health expenses. This study examines the present classification of patent applications for insulin in Brazil. The search for patent documents was carried out using an Orbit Intelligence® database. The results show an absence in Brazil of national industries innovating by means of patents in the biotechnology area, becoming it dependent on external market, which can result in a national insulin shortage supply. Taking account the three countries studied, only the United States of America has a number of patents for insulin that demonstrates progress and investment in research and development. It is necessary to increase investment in R&D and public policy-making encouraging innovation of the studies in the biotechnology area in Brazil.

Author Biographies

Carlos Eduardo Collazo Pontes, Fundação Oswaldo Cruz, Instituto de Tecnologia em Fármacos, Núcleo de Inovação Tecnológica. Rio de Janeiro, RJ

Mestrado em Gestão, Pesquisa e Desenvolvimento na Indústria Farmacêutica pela Fundação Oswaldo Cruz.

Wanise Borges Gouvea Barroso, Fundação Oswaldo Cruz, Instituto de Tecnologia em Fármacos, Núcleo de Inovação Tecnológica. Rio de Janeiro, RJ

Doutorado em Sciences de l’Information et de la Communication pela Universite de Toulon.

Downloads

Published

2018-12-24

How to Cite

Pontes, C. E. C., & Barroso, W. B. G. (2018). Analysis of the patent applications for insulin in Brazil. Revista Eletrônica De Comunicação, Informação & Inovação Em Saúde, 12(4). https://doi.org/10.29397/reciis.v12i4.1328

Issue

Vol. 12 No. 4 (2018)

Section

Original articles

License

Author’s rights:  The author retains unrestricted rights over his work.

Rights to reuse: Reciis adopts the Creative Commons License, CC BY-NC non-commercial attribution according to the Policy on Open Access to Knowledge by Oswaldo Cruz Foundation. With this license, access, download, copy, print, share, reuse, and distribution of articles is allowed, provided that it is for non-commercial use and with source citation, granting proper authorship credits and reference to Reciis. In such cases, no permission is required from the authors or editors.

Rights of authors’s deposit / self-archiving: The authors are encouraged to deposit the published version, along with the link of their article in Reciis, in institutional repositories.